Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD.
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine if treatment with pantoprazole 40 mg daily
versus a placebo improves sleep quality in patients with gastroesophageal reflux disease
(GERD). Another purpose is to determine if treatment with pantoprazole 40 mg once daily
versus a placebo improves sleep outcomes in patients with gastroesophageal reflux disease
using spectral analysis of sleep electroencephalogram (EEG).